IL324976A - טיפולים משולבים עבור דיכאון והפרעות אחרות - Google Patents
טיפולים משולבים עבור דיכאון והפרעות אחרותInfo
- Publication number
- IL324976A IL324976A IL324976A IL32497625A IL324976A IL 324976 A IL324976 A IL 324976A IL 324976 A IL324976 A IL 324976A IL 32497625 A IL32497625 A IL 32497625A IL 324976 A IL324976 A IL 324976A
- Authority
- IL
- Israel
- Prior art keywords
- dosage form
- hours
- maoi
- beta blocker
- subject
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363521578P | 2023-06-16 | 2023-06-16 | |
| US202363528285P | 2023-07-21 | 2023-07-21 | |
| US202463638117P | 2024-04-24 | 2024-04-24 | |
| PCT/US2024/034303 WO2024259412A2 (en) | 2023-06-16 | 2024-06-17 | Combination treatments for depression and other disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL324976A true IL324976A (he) | 2026-01-01 |
Family
ID=93852723
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL324976A IL324976A (he) | 2023-06-16 | 2024-06-17 | טיפולים משולבים עבור דיכאון והפרעות אחרות |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP4727545A2 (he) |
| CN (1) | CN121712501A (he) |
| AU (1) | AU2024302180A1 (he) |
| IL (1) | IL324976A (he) |
| WO (1) | WO2024259412A2 (he) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2768338B1 (fr) * | 1997-09-17 | 1999-10-15 | Synthelabo | Compositions pharmaceutiques contenant un inhibiteur de la monoamine oxydase et leur application en therapeutique |
| US20100143507A1 (en) * | 2008-12-09 | 2010-06-10 | Auspex Pharmaceuticals, Inc. | Carboxylic acid inhibitors of histone deacetylase, gaba transaminase and sodium channel |
| WO2020168337A1 (en) * | 2019-02-17 | 2020-08-20 | Magid Abraham | Compositions and methods for treatment of depression and other disorders |
| EP4297868A4 (en) * | 2021-02-23 | 2025-01-08 | Hoth Therapeutics, Inc. | USE OF APREPITANT TO TREAT ALZHEIMER'S |
-
2024
- 2024-06-17 EP EP24824340.4A patent/EP4727545A2/en active Pending
- 2024-06-17 IL IL324976A patent/IL324976A/he unknown
- 2024-06-17 CN CN202480039874.XA patent/CN121712501A/zh active Pending
- 2024-06-17 AU AU2024302180A patent/AU2024302180A1/en active Pending
- 2024-06-17 WO PCT/US2024/034303 patent/WO2024259412A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2024259412A3 (en) | 2025-05-15 |
| AU2024302180A1 (en) | 2026-02-05 |
| CN121712501A (zh) | 2026-03-20 |
| WO2024259412A2 (en) | 2024-12-19 |
| EP4727545A2 (en) | 2026-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101784777B1 (ko) | 타펜타돌 조성물 | |
| EP2531181B1 (en) | Extended release formulations of rasagiline and uses thereof | |
| US20080021074A1 (en) | Pharmaceutical Compositions and Related Methods of Treatment | |
| US20030203055A1 (en) | Methods of treating visceral pain syndromes | |
| US20110319384A1 (en) | Pharmaceutical Compositions | |
| RS56523B1 (sr) | Tapentadol za sprečavanje i lečenje depresije i anksioznosti | |
| US20190133971A1 (en) | Pharmaceutical Combination | |
| JP7127832B2 (ja) | マジンドールのｉｒ／ｓｒ多層錠剤及び該錠剤の注意欠陥／多動性障害（ａｄｈｄ）の治療のための使用 | |
| US11890261B2 (en) | Composition and method for treating neurological disease | |
| US10500170B2 (en) | Composition and method for treating neurological disease | |
| US11833121B2 (en) | Composition and method for treating neurological disease | |
| IL324976A (he) | טיפולים משולבים עבור דיכאון והפרעות אחרות | |
| CN112804992A (zh) | 较高剂量的改良释放石杉碱制剂的用途 | |
| US20110027324A1 (en) | O-desmethyl-venlafaxine for treating major depressive disorder | |
| CN113631157A (zh) | 用于治疗抑郁症和其它病症的组合物和方法 | |
| US20240009181A1 (en) | Method for the treatment and prophylaxis of substance-related and/or addictive disorders including substance/medication-induced depressive disorders, bipolar and related disorders, and anxiety disorders and compositions useful for the same | |
| CA2493490A1 (en) | Treatment of depression secondary to pain (dsp) | |
| KR101151342B1 (ko) | 에페리손 함유 필름코팅정제, 및 이의 제조방법 | |
| Solárová | NEW APPROACHES IN THE ANTIPARKINSONIAL THERAPY. | |
| WO2025188619A1 (en) | Methods of treating parkinson's disease with t-type calcium channel modulators | |
| HK40066088A (en) | A mazindol ir/sr multilayer tablet and its use for the treatment of attention deficit/hyperactivity disorder (adhd) | |
| WO2024249560A1 (en) | Solriamfetol for treating cognitive impairment in a subject with impaired cognition associated with obstructive sleep apnea and excessive daytime sleepiness | |
| KR20120103521A (ko) | 에페리손 함유 필름코팅정제, 및 이의 제조방법 | |
| KR20130106023A (ko) | 에페리손 함유 필름코팅정제, 및 이의 제조방법 |